_id
691485f6ccc777a4e85d9604
Ticker
NXTC
Name
NextCure Inc
Exchange
NASDAQ
Address
9000 Virginia Manor Road, Beltsville, MD, United States, 20705
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.nextcure.com
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
Last Close
11.39
Volume
36289
Current Price
11.38
Change
-0.08779631255487082
Last Updated
2025-12-02T12:54:25.760Z
Image
-
Ipo Date
2019-05-09T00:00:00.000Z
Market Cap
45436432
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.995
Sentiment Sources
1
Rating
4
Target Price
17.6667
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
8945000
Operating Income
-8945000
Interest Expense
-
Pretax Income
-8624000
Net Income
-8624000
Eps
-3.2225807849883936
Dividends Per Share
-
Shares Outstanding
3388250
Income Tax Expense
-
EBITDA
-8091000
Operating Margin
-
Total Other Income Expense Net
321000
Cash
7324000
Short Term Investments
21786000
Receivables
-
Inventories
-
Total Current Assets
32640000
Property Plant Equipment
6423000
Total Assets
39613000
Payables
2391000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
15967000
Equity
23646000
Depreciation
533000
Change In Working Capital
1121000
Cash From Operations
-6268000
Capital Expenditures
0
Cash From Investing
8700000
Cash From Financing
0
Net Change In Cash
2432000
PE
-
PB
1.2879218506301278
ROE
-36.4712847838958
ROA
-21.770630853507686
FCF
-6268000
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
8945000
Quarters > 0 > income Statement > operating Income
-8945000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-8624000
Quarters > 0 > income Statement > net Income
-8624000
Quarters > 0 > income Statement > eps
-3.2225807849883936
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2676116
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-8091000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
321000
Quarters > 0 > balance Sheet > cash
7324000
Quarters > 0 > balance Sheet > short Term Investments
21786000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
32640000
Quarters > 0 > balance Sheet > property Plant Equipment
6423000
Quarters > 0 > balance Sheet > total Assets
39613000
Quarters > 0 > balance Sheet > payables
2391000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
15967000
Quarters > 0 > balance Sheet > equity
23646000
Quarters > 0 > cash Flow > net Income
-8624000
Quarters > 0 > cash Flow > depreciation
533000
Quarters > 0 > cash Flow > change In Working Capital
1121000
Quarters > 0 > cash Flow > cash From Operations
-6268000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
8700000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
2432000
Quarters > 0 > ratios > PE
-3.2225807849883936
Quarters > 0 > ratios > PB
1.2879218506301278
Quarters > 0 > ratios > ROE
-36.4712847838958
Quarters > 0 > ratios > ROA
-21.770630853507686
Quarters > 0 > ratios > FCF
-6268000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
633000
Quarters > 1 > income Statement > gross Profit
-633000
Quarters > 1 > income Statement > operating Expenses
27292000
Quarters > 1 > income Statement > operating Income
-27292000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-26808000
Quarters > 1 > income Statement > net Income
-26808000
Quarters > 1 > income Statement > eps
-11.288824282931422
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2374738
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-26659000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
484000
Quarters > 1 > balance Sheet > cash
4892000
Quarters > 1 > balance Sheet > short Term Investments
30416000
Quarters > 1 > balance Sheet > receivables
200000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
40015000
Quarters > 1 > balance Sheet > property Plant Equipment
7119000
Quarters > 1 > balance Sheet > total Assets
47689000
Quarters > 1 > balance Sheet > payables
2544000
Quarters > 1 > balance Sheet > short Term Debt
639000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
16043000
Quarters > 1 > balance Sheet > equity
31646000
Quarters > 1 > cash Flow > net Income
-26808000
Quarters > 1 > cash Flow > depreciation
247000
Quarters > 1 > cash Flow > change In Working Capital
2877000
Quarters > 1 > cash Flow > cash From Operations
-22713000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
3759000
Quarters > 1 > cash Flow > cash From Financing
2019000
Quarters > 1 > cash Flow > net Change In Cash
-16935000
Quarters > 1 > ratios > PE
-11.288824282931422
Quarters > 1 > ratios > PB
0.8539631688049043
Quarters > 1 > ratios > ROE
-84.71212791506035
Quarters > 1 > ratios > ROA
-56.21422130889723
Quarters > 1 > ratios > FCF
-22713000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
654000
Quarters > 2 > income Statement > gross Profit
-654000
Quarters > 2 > income Statement > operating Expenses
11622000
Quarters > 2 > income Statement > operating Income
-11622000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-10976000
Quarters > 2 > income Statement > net Income
-10976000
Quarters > 2 > income Statement > eps
-4.7028780276705415
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
2333890
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-10968000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
646000
Quarters > 2 > balance Sheet > cash
21827000
Quarters > 2 > balance Sheet > short Term Investments
34033000
Quarters > 2 > balance Sheet > receivables
300000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
58897000
Quarters > 2 > balance Sheet > property Plant Equipment
7912000
Quarters > 2 > balance Sheet > total Assets
67137000
Quarters > 2 > balance Sheet > payables
2736000
Quarters > 2 > balance Sheet > short Term Debt
929000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
11282000
Quarters > 2 > balance Sheet > equity
55855000
Quarters > 2 > cash Flow > net Income
-10976000
Quarters > 2 > cash Flow > depreciation
654000
Quarters > 2 > cash Flow > change In Working Capital
-3940000
Quarters > 2 > cash Flow > cash From Operations
-12994000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
7094000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-5900000
Quarters > 2 > ratios > PE
-4.7028780276705415
Quarters > 2 > ratios > PB
0.4755110231850327
Quarters > 2 > ratios > ROE
-19.650881747381614
Quarters > 2 > ratios > ROA
-16.348660202272963
Quarters > 2 > ratios > FCF
-12994000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
3282000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
1641000
Quarters > 3 > income Statement > operating Expenses
12455000
Quarters > 3 > income Statement > operating Income
-12455000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-11603000
Quarters > 3 > income Statement > net Income
-11603000
Quarters > 3 > income Statement > eps
-4.971528221124389
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2333890
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-11781000
Quarters > 3 > income Statement > operating Margin
-379.4942108470445
Quarters > 3 > income Statement > total Other Income Expense Net
852000
Quarters > 3 > balance Sheet > cash
27727000
Quarters > 3 > balance Sheet > short Term Investments
40894000
Quarters > 3 > balance Sheet > receivables
300000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
71807000
Quarters > 3 > balance Sheet > property Plant Equipment
8721000
Quarters > 3 > balance Sheet > total Assets
80860000
Quarters > 3 > balance Sheet > payables
5353000
Quarters > 3 > balance Sheet > short Term Debt
796000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
15388000
Quarters > 3 > balance Sheet > equity
65472000
Quarters > 3 > cash Flow > net Income
-11603000
Quarters > 3 > cash Flow > depreciation
674000
Quarters > 3 > cash Flow > change In Working Capital
2585000
Quarters > 3 > cash Flow > cash From Operations
-6969000
Quarters > 3 > cash Flow > capital Expenditures
34000
Quarters > 3 > cash Flow > cash From Investing
6958000
Quarters > 3 > cash Flow > cash From Financing
36000
Quarters > 3 > cash Flow > net Change In Cash
25000
Quarters > 3 > ratios > PE
-4.971528221124389
Quarters > 3 > ratios > PB
0.40566453140273706
Quarters > 3 > ratios > ROE
-17.722079667644184
Quarters > 3 > ratios > ROA
-14.349492950779124
Quarters > 3 > ratios > FCF
-7003000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-2.1337599024984764
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2865000
Annuals > 0 > income Statement > gross Profit
-2865000
Annuals > 0 > income Statement > operating Expenses
59748000
Annuals > 0 > income Statement > operating Income
-59748000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-55654000
Annuals > 0 > income Statement > net Income
-55654000
Annuals > 0 > income Statement > eps
-23.88188051249879
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
2330386
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-54341000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
4094000
Annuals > 0 > balance Sheet > cash
27727000
Annuals > 0 > balance Sheet > short Term Investments
40894000
Annuals > 0 > balance Sheet > receivables
300000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
71807000
Annuals > 0 > balance Sheet > property Plant Equipment
8721000
Annuals > 0 > balance Sheet > total Assets
80860000
Annuals > 0 > balance Sheet > payables
5353000
Annuals > 0 > balance Sheet > short Term Debt
796000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
15388000
Annuals > 0 > balance Sheet > equity
65472000
Annuals > 0 > cash Flow > net Income
-55654000
Annuals > 0 > cash Flow > depreciation
2865000
Annuals > 0 > cash Flow > change In Working Capital
4532000
Annuals > 0 > cash Flow > cash From Operations
-40805000
Annuals > 0 > cash Flow > capital Expenditures
474000
Annuals > 0 > cash Flow > cash From Investing
55306000
Annuals > 0 > cash Flow > cash From Financing
144000
Annuals > 0 > cash Flow > net Change In Cash
14645000
Annuals > 0 > ratios > PE
-23.88188051249879
Annuals > 0 > ratios > PB
0.47731054893695013
Annuals > 0 > ratios > ROE
-85.00427663734116
Annuals > 0 > ratios > ROA
-68.82760326490231
Annuals > 0 > ratios > FCF
-41279000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
3684000
Annuals > 1 > income Statement > gross Profit
-3684000
Annuals > 1 > income Statement > operating Expenses
67637000
Annuals > 1 > income Statement > operating Income
-67637000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-62723000
Annuals > 1 > income Statement > net Income
-62723000
Annuals > 1 > income Statement > eps
-27.03909747533641
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2319715
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-63953000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
4914000
Annuals > 1 > balance Sheet > cash
13082000
Annuals > 1 > balance Sheet > short Term Investments
95217000
Annuals > 1 > balance Sheet > receivables
800000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
112725000
Annuals > 1 > balance Sheet > property Plant Equipment
13431000
Annuals > 1 > balance Sheet > total Assets
128038000
Annuals > 1 > balance Sheet > payables
2330000
Annuals > 1 > balance Sheet > short Term Debt
656000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
13617000
Annuals > 1 > balance Sheet > equity
114421000
Annuals > 1 > cash Flow > net Income
-62723000
Annuals > 1 > cash Flow > depreciation
3684000
Annuals > 1 > cash Flow > change In Working Capital
-1940000
Annuals > 1 > cash Flow > cash From Operations
-52974000
Annuals > 1 > cash Flow > capital Expenditures
820000
Annuals > 1 > cash Flow > cash From Investing
39272000
Annuals > 1 > cash Flow > cash From Financing
154000
Annuals > 1 > cash Flow > net Change In Cash
-13548000
Annuals > 1 > ratios > PE
-27.03909747533641
Annuals > 1 > ratios > PB
0.27186773538074305
Annuals > 1 > ratios > ROE
-54.817734506777605
Annuals > 1 > ratios > ROA
-48.98780049672754
Annuals > 1 > ratios > FCF
-53794000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
4480000
Annuals > 2 > income Statement > gross Profit
-4480000
Annuals > 2 > income Statement > operating Expenses
75909000
Annuals > 2 > income Statement > operating Income
-75909000
Annuals > 2 > income Statement > interest Expense
5300000
Annuals > 2 > income Statement > pretax Income
-74733000
Annuals > 2 > income Statement > net Income
-69433000
Annuals > 2 > income Statement > eps
-30.031353575687376
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2312017
Annuals > 2 > income Statement > income Tax Expense
-5300000
Annuals > 2 > income Statement > EBITDA
-71785000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1176000
Annuals > 2 > balance Sheet > cash
26630000
Annuals > 2 > balance Sheet > short Term Investments
133281000
Annuals > 2 > balance Sheet > receivables
700000
Annuals > 2 > balance Sheet > inventories
-700000
Annuals > 2 > balance Sheet > total Current Assets
163983000
Annuals > 2 > balance Sheet > property Plant Equipment
16913000
Annuals > 2 > balance Sheet > total Assets
184161000
Annuals > 2 > balance Sheet > payables
4270000
Annuals > 2 > balance Sheet > short Term Debt
518000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
16631000
Annuals > 2 > balance Sheet > equity
167530000
Annuals > 2 > cash Flow > net Income
-74733000
Annuals > 2 > cash Flow > depreciation
4124000
Annuals > 2 > cash Flow > change In Working Capital
3725000
Annuals > 2 > cash Flow > cash From Operations
-53886000
Annuals > 2 > cash Flow > capital Expenditures
2116000
Annuals > 2 > cash Flow > cash From Investing
67979000
Annuals > 2 > cash Flow > cash From Financing
200000
Annuals > 2 > cash Flow > net Change In Cash
14293000
Annuals > 2 > ratios > PE
-30.031353575687376
Annuals > 2 > ratios > PB
0.18506624467259594
Annuals > 2 > ratios > ROE
-41.445114307885156
Annuals > 2 > ratios > ROA
-37.70233654248185
Annuals > 2 > ratios > FCF
-56002000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
4300000
Annuals > 3 > income Statement > gross Profit
-4300000
Annuals > 3 > income Statement > operating Expenses
70765000
Annuals > 3 > income Statement > operating Income
-70765000
Annuals > 3 > income Statement > interest Expense
77000
Annuals > 3 > income Statement > pretax Income
-69389000
Annuals > 3 > income Statement > net Income
-69389000
Annuals > 3 > income Statement > eps
-30.151681787626377
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2301331
Annuals > 3 > income Statement > income Tax Expense
6959442
Annuals > 3 > income Statement > EBITDA
-66588000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
1376000
Annuals > 3 > balance Sheet > cash
12337000
Annuals > 3 > balance Sheet > short Term Investments
207254000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
227817000
Annuals > 3 > balance Sheet > property Plant Equipment
13992000
Annuals > 3 > balance Sheet > total Assets
242386000
Annuals > 3 > balance Sheet > payables
1942000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
9000000
Annuals > 3 > balance Sheet > equity
233386000
Annuals > 3 > cash Flow > net Income
-69389000
Annuals > 3 > cash Flow > depreciation
7196000
Annuals > 3 > cash Flow > change In Working Capital
-5339000
Annuals > 3 > cash Flow > cash From Operations
-57244000
Annuals > 3 > cash Flow > capital Expenditures
2360000
Annuals > 3 > cash Flow > cash From Investing
36601000
Annuals > 3 > cash Flow > cash From Financing
-3265000
Annuals > 3 > cash Flow > net Change In Cash
-23908000
Annuals > 3 > ratios > PE
-30.151681787626377
Annuals > 3 > ratios > PB
0.13223093377494796
Annuals > 3 > ratios > ROE
-29.731432048194833
Annuals > 3 > ratios > ROA
-28.62747848473097
Annuals > 3 > ratios > FCF
-59604000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-3.2225807849883936
Valuation > metrics > PB
1.2879218506301278
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-36.4712847838958
Profitability > metrics > ROA
-26.42156862745098
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6752516281823564
Risk > metrics > Interest Coverage
-16.78236397748593
Risk > final Score
-19
Risk > verdict
High
Liquidity > metrics > Current Ratio
13.651191969887076
Liquidity > metrics > Quick Ratio
13.651191969887076
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-685
Prev Risks > 1
-5751
Prev Risks > 2
-220
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:08:35.292Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-3.22
Earnings History > 0 > eps Estimate
-0.45
Earnings History > 0 > eps Difference
-2.77
Earnings History > 0 > surprise Percent
-615.5556
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-31
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-11.29
Earnings History > 1 > eps Estimate
-0.425
Earnings History > 1 > eps Difference
-10.865
Earnings History > 1 > surprise Percent
-2556.4706
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.39
Earnings History > 2 > eps Estimate
-0.4
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
2.5
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-19
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.41
Earnings History > 3 > eps Estimate
-0.36
Earnings History > 3 > eps Difference
-0.05
Earnings History > 3 > surprise Percent
-13.8889
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-04
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.41
Earnings History > 4 > eps Estimate
-0.34
Earnings History > 4 > eps Difference
-0.07
Earnings History > 4 > surprise Percent
-20.5882
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-01
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.55
Earnings History > 5 > eps Estimate
-0.38
Earnings History > 5 > eps Difference
-0.17
Earnings History > 5 > surprise Percent
-44.7368
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-02
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.61
Earnings History > 6 > eps Estimate
-0.46
Earnings History > 6 > eps Difference
-0.15
Earnings History > 6 > surprise Percent
-32.6087
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-21
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.52
Earnings History > 7 > eps Estimate
-0.54
Earnings History > 7 > eps Difference
0.02
Earnings History > 7 > surprise Percent
3.7037
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-02
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.51
Earnings History > 8 > eps Estimate
-0.66
Earnings History > 8 > eps Difference
0.15
Earnings History > 8 > surprise Percent
22.7273
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.64
Earnings History > 9 > eps Estimate
-0.59
Earnings History > 9 > eps Difference
-0.05
Earnings History > 9 > surprise Percent
-8.4746
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.58
Earnings History > 10 > eps Estimate
-0.64
Earnings History > 10 > eps Difference
0.06
Earnings History > 10 > surprise Percent
9.375
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-02
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.62
Earnings History > 11 > eps Estimate
-0.66
Earnings History > 11 > eps Difference
0.04
Earnings History > 11 > surprise Percent
6.0606
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.68
Earnings History > 12 > eps Estimate
-0.63
Earnings History > 12 > eps Difference
-0.05
Earnings History > 12 > surprise Percent
-7.9365
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.65
Earnings History > 13 > eps Estimate
-0.72
Earnings History > 13 > eps Difference
0.07
Earnings History > 13 > surprise Percent
9.7222
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-05
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.74
Earnings History > 14 > eps Estimate
-0.67
Earnings History > 14 > eps Difference
-0.07
Earnings History > 14 > surprise Percent
-10.4478
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-03
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.61
Earnings History > 15 > eps Estimate
-0.67
Earnings History > 15 > eps Difference
0.06
Earnings History > 15 > surprise Percent
8.9552
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-04
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.65
Earnings History > 16 > eps Estimate
-0.67
Earnings History > 16 > eps Difference
0.02
Earnings History > 16 > surprise Percent
2.9851
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-05
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.65
Earnings History > 17 > eps Estimate
-0.61
Earnings History > 17 > eps Difference
-0.04
Earnings History > 17 > surprise Percent
-6.5574
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.6
Earnings History > 18 > eps Estimate
-0.59
Earnings History > 18 > eps Difference
-0.01
Earnings History > 18 > surprise Percent
-1.6949
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-04
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.54
Earnings History > 19 > eps Estimate
-0.6
Earnings History > 19 > eps Difference
0.06
Earnings History > 19 > surprise Percent
10
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.59
Earnings History > 20 > eps Estimate
-0.57
Earnings History > 20 > eps Difference
-0.02
Earnings History > 20 > surprise Percent
-3.5088
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-06
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.53
Earnings History > 21 > eps Estimate
-0.5
Earnings History > 21 > eps Difference
-0.03
Earnings History > 21 > surprise Percent
-6
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
0.33
Earnings History > 22 > eps Estimate
-0.44
Earnings History > 22 > eps Difference
0.77
Earnings History > 22 > surprise Percent
175
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-12
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.34
Earnings History > 23 > eps Estimate
-0.45
Earnings History > 23 > eps Difference
0.11
Earnings History > 23 > surprise Percent
24.4444
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-12
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.37
Earnings History > 24 > eps Estimate
-0.35
Earnings History > 24 > eps Difference
-0.02
Earnings History > 24 > surprise Percent
-5.7143
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-12
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.61
Earnings History > 25 > eps Estimate
-0.46
Earnings History > 25 > eps Difference
-0.15
Earnings History > 25 > surprise Percent
-32.6087
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-06-10
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-4.46
Earnings History > 26 > eps Estimate
-0.53
Earnings History > 26 > eps Difference
-3.93
Earnings History > 26 > surprise Percent
-741.5094
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ANextCure files for offering of up to 2.52 million shares of common stock by selling stockholders - SEC filing marketscreener.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$17.6667
Analyst Picks
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 42.30% of the total shares of NextCure Inc
1.
Sofinnova Ventures(8.3201%)
since
2025/03/31
2.
Affinity Asset Advisors, LLC(7.1702%)
since
2025/03/31
3.
Pfizer Inc(5.8909%)
since
2025/03/31
4.
Citigroup Inc(4.4199%)
since
2025/03/31
5.
Vanguard Group Inc(3.0745%)
since
2025/03/31
6.
Cable Car Capital LLC(2.0867%)
since
2025/03/31
7.
Vanguard Total Stock Mkt Idx Inv(1.8706%)
since
2025/07/31
8.
BlackRock Inc(1.7335%)
since
2025/03/31
9.
Renaissance Technologies Corp(1.4946%)
since
2025/03/31
10.
CARDIFF PARK ADVISORS, LLC(0.8159%)
since
2025/03/31
11.
Geode Capital Management, LLC(0.7355%)
since
2025/03/31
12.
Macquarie Group Ltd(0.4671%)
since
2025/03/31
13.
Macquarie Healthcare I(0.4671%)
since
2025/07/31
14.
Vanguard Institutional Extnd Mkt Idx Tr(0.4321%)
since
2025/07/31
15.
Sio Capital Management, LLC(0.4048%)
since
2025/03/31
16.
Fidelity Extended Market Index(0.3843%)
since
2025/07/31
17.
ADAR1 Capital Management LLC(0.3737%)
since
2025/03/31
18.
Armistice Capital, LLC(0.3239%)
since
2025/03/31
19.
Citadel Advisors Llc(0.2823%)
since
2025/03/31
20.
Barclays PLC(0.2102%)
since
2025/03/31
21.
State Street Corp(0.2036%)
since
2025/03/31
22.
Vanguard Explorer Inv(0.1751%)
since
2025/06/30
23.
Northern Trust Corp(0.1479%)
since
2025/03/31
24.
IEQ CAPITAL, LLC(0.1163%)
since
2025/03/31
25.
Fidelity Series Total Market Index(0.0953%)
since
2025/07/31
26.
Spartan Extended Market Index Pool F(0.0943%)
since
2025/07/31
27.
NT Ext Equity Mkt Idx Fd - L(0.0857%)
since
2025/06/30
28.
Northern Trust Extended Eq Market Idx(0.0857%)
since
2025/06/30
29.
Extended Equity Market Fund K(0.0788%)
since
2025/06/30
30.
Schonfeld Strategic Advisors LLC(0.059%)
since
2025/03/31
31.
NT Ext Equity Mkt Idx Fd - NL(0.0453%)
since
2025/06/30
32.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0352%)
since
2025/06/30
33.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0242%)
since
2025/06/30
34.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0204%)
since
2024/12/31
35.
U.S. Equity Market Fund F(0.0167%)
since
2025/06/30
36.
NT Quality Small Cap Core(0.0129%)
since
2025/06/30
37.
NT Quality SCC US Fund - L(0.0129%)
since
2025/06/30
38.
BNYM Mellon SL Market Completion UC1(0.0127%)
since
2025/06/30
39.
Extended Equity Market Fund M(0.0099%)
since
2025/06/30
40.
Diversified Equity Fund F(0.0079%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-3.22
EPS Estimate
-0.45
EPS Difference
-2.77
Surprise Percent
-615.5556%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.